An investigation uncovers a rapidly growing, highly lucrative shadow market in South Africa for unapproved weight-loss drugs like Retatrutide, sold openly online and in gyms despite severe health warnings from regulators. These experimental injectables pose significant risks due to unknown composition and lack of sterility.